Breast Cancer Research

official impact factor 5.79
Search for
Advanced search
Breast Cancer Research
Tools
Share this article

New targets for therapy in breast cancer: Farnesyltransferase inhibitors

Julia Head and Stephen RD Johnston*

Breast Cancer Res 2004, 6:262-268 doi:10.1186/bcr947

Accesses  

  • Last 30 days: 42 accesses
  • Last 365 days: 475 accesses
  • All time: 4881 accesses

Cited by

BioMed Central: 2 citations

Research article   Open Access Highly Accessed

Reversible inactivation of the transcriptional function of P53 protein by farnesylation

Bettina Couderc, Marie Penary, Mustapha Tohfe, Anne Pradines, Antoine Casteignau, Danièle Berg, Gilles Favre BMC Biotechnology 2006, 6:26 (29 May 2006)

Abstract | Full text | PDF | PubMed

Research article   Open Access

Farnesyl-transferase inhibitor R115,777 enhances tamoxifen inhibition of MCF-7 cell growth through estrogen receptor dependent and independent pathways

Florence Dalenc, Claire Giamarchi, Mélissa Petit, Marc Poirot, Gilles Favre, Jean-Charles Faye Breast Cancer Research 2005, 7:R1159-R1167 (21 November 2005)

Abstract | Full text | PDF | PubMed

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations